Another Trump Appointee Learns It’s Easier to Be a Critic Than a Leader
The New York Times
Overall Assessment
The article critiques Dr. Makary’s FDA leadership through a strong moral and institutional lens, emphasizing lost trust and mismanagement. It provides useful context on public health system challenges but lacks source diversity and objectivity. The framing prioritizes advocacy over balanced reporting.
"Dr. Marty Markary, who resigned as head of the Food and Drug Administration on Tuesday, is the latest to learn that it’s easier to criticize a system from the outside than to change it from the inside."
Narrative Framing
Headline & Lead 25/100
The headline and lead frame Dr. Makary’s resignation as a personal failure rooted in hypocrisy, using judgmental language and a moralistic tone rather than neutrally presenting the event and its implications.
✕ Loaded Language: The headline uses a subjective and dismissive tone toward a public official's leadership failure, framing the story through a moral judgment rather than a neutral summary of events.
"Another Trump Appointee Learns It’s Easier to Be a Critic Than a Leader"
✕ Narrative Framing: The opening paragraph immediately frames Dr. Makary’s tenure as a failure due to the difficulty of leading versus criticizing, setting a negative and predetermined narrative without presenting evidence upfront.
"Dr. Marty Markary, who resigned as head of the Food and Drug Administration on Tuesday, is the latest to learn that it’s easier to criticize a system from the outside than to change it from the inside."
Language & Tone 20/100
The tone is highly opinionated and emotionally charged, using moral judgment and vivid examples of harm to condemn leadership decisions rather than maintaining a neutral, explanatory stance.
✕ Loaded Language: The article uses emotionally charged language to describe institutional decline, such as 'plummeted', 'dismantled', and 'destruction without a plan', amplifying alarm.
"Trust in the agency — among the public and among the scientists who make the work happen — has plummeted."
✕ Editorializing: The author frames Makary’s actions as 'performative disruption' and 'showy headlines', implying insincerity and theatricality rather than genuine reform.
"But overall, we’ve witnessed the erosion of the agency’s prestige and capacity: inconsistent standards, showy headlines at the expense of serious priorities..."
✕ Appeal To Emotion: The article appeals to fear by linking policy decisions directly to individual suffering, such as a pregnant woman denied Tylenol over unfounded fears.
"a pregnant woman in an emergency department who actually needed Tylenol to reduce a fever, but didn’t get it out of unfounded fears that it could cause autism."
✕ Framing By Emphasis: The author acknowledges Makary’s resignation over vape policy as 'admirable' but immediately dismisses it as 'too late', maintaining a critical stance throughout.
"But it also comes too late. Dr. Makary’s tenure is just the latest in a cautionary tale about performative disruption..."
Balance 30/100
The article lacks balanced sourcing, relying solely on the author’s perspective without including voices from the subject, his supporters, or neutral institutional experts.
✕ Vague Attribution: The article is written by Dr. Katelyn Jetelina, a public health scientist, but is presented as an opinion piece without counter-quotes from supporters of Dr. Makary or administration officials.
"Katelyn Jetelina is a public health scientist and science communicator."
✕ Vague Attribution: While the author cites broad stakeholder dependence on the FDA, no specific named sources or officials are quoted to support claims about declining trust or staff departures.
"Trust in the agency — among the public and among the scientists who make the work happen — has plummeted."
✕ Omission: The article briefly acknowledges Dr. Makary’s accomplishments but does not include any direct quotes or perspectives from him, his team, or allies.
"Dr. Makary can boast some laudable wins from his time at the F.D.A., such as leveraging artificial intelligence to monitor clinical trials in real time..."
Completeness 75/100
The article provides meaningful historical and systemic context about public health institutions, including their pre-existing weaknesses and the pressures of recent crises.
✓ Comprehensive Sourcing: The article acknowledges historical limitations of the FDA, such as being slow to adapt and opaque, providing necessary context for understanding institutional inertia.
"At times, it has been slow to adapt, limited in focus, opaque about its data and captive to a culture of caution."
✓ Comprehensive Sourcing: The piece notes that public health institutions were outdated and unprepared for a crisis like Covid-19, adding context for why reform was needed.
"It’s true that our public health institutions were largely designed for another time; they were not working as well as they could have."
✓ Comprehensive Sourcing: The article references the hantavirus outbreak as a timely context for assessing public health leadership failures, grounding the critique in a real-world consequence.
"This week, as our country and the globe confront a hantavirus outbreak, the all-too-predictable effects of destruction without a plan have become clear."
Government leadership portrayed as untrustworthy and damaging to institutions
Editorializing and loaded language depict leadership decisions as performative and reckless
"But overall, we’ve witnessed the erosion of the agency’s prestige and capacity: inconsistent standards, showy headlines at the expense of serious priorities, and immense confusion about what scientific evidence does and does not say."
FDA portrayed as failing to ensure public safety
Loaded language and emotional examples used to emphasize institutional breakdown and real-world harm
"Trust in the agency — among the public and among the scientists who make the work happen — has plummeted."
Public health leadership framed as causing direct harm to individuals
Appeal to emotion through vivid, individualized examples of harm linked to policy decisions
"a pregnant woman in an emergency department who actually needed Tylenol to reduce a fever, but didn’t get it out of unfounded fears that it could cause autism."
Public health institutions framed as ineffective and broken
Framing by emphasis on systemic dismantling and loss of capacity, with broad claims of failure
"Over the past year and a half, many parts of the U.S. public health system have been dismantled. Staff have been fired, seemingly haphazardly; funding for core data systems, logistics and community partnerships has been cut..."
Trump appointees framed as adversarial to competent governance
Narrative framing in headline and lead positions appointees as critics-turned-failures, implying inherent unsuitability for leadership
"Another Trump Appointee Learns It’s Easier to Be a Critic Than a Leader"
The article critiques Dr. Makary’s FDA leadership through a strong moral and institutional lens, emphasizing lost trust and mismanagement. It provides useful context on public health system challenges but lacks source diversity and objectivity. The framing prioritizes advocacy over balanced reporting.
Dr. Marty Makary has resigned as FDA commissioner, leaving the agency without permanent leadership during an ongoing hantavirus outbreak. The article outlines criticisms of his tenure, including declining morale and transparency, while also noting some reforms. Public health infrastructure across HHS, CDC, and other agencies remains understaffed and in transition.
The New York Times — Lifestyle - Health
Based on the last 60 days of articles
The New York Times
